NZ211827A - Production of polypeptides having interferon activity, polypeptide compositions and dna - Google Patents

Production of polypeptides having interferon activity, polypeptide compositions and dna

Info

Publication number
NZ211827A
NZ211827A NZ211827A NZ21182785A NZ211827A NZ 211827 A NZ211827 A NZ 211827A NZ 211827 A NZ211827 A NZ 211827A NZ 21182785 A NZ21182785 A NZ 21182785A NZ 211827 A NZ211827 A NZ 211827A
Authority
NZ
New Zealand
Prior art keywords
dna
polypeptides
production
sequences
polypeptide compositions
Prior art date
Application number
NZ211827A
Other languages
English (en)
Inventor
J Engels
M Leineweber
E Uhlmann
W Ulmer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ211827A publication Critical patent/NZ211827A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ211827A 1984-04-19 1985-04-17 Production of polypeptides having interferon activity, polypeptide compositions and dna NZ211827A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843414831 DE3414831A1 (de) 1984-04-19 1984-04-19 Herstellung von polypeptiden mit human-gammainterferon-aktivitaet

Publications (1)

Publication Number Publication Date
NZ211827A true NZ211827A (en) 1988-07-28

Family

ID=6234006

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211827A NZ211827A (en) 1984-04-19 1985-04-17 Production of polypeptides having interferon activity, polypeptide compositions and dna

Country Status (20)

Country Link
US (1) US4832959A (enExample)
EP (1) EP0161504B1 (enExample)
JP (2) JPH0745516B2 (enExample)
KR (1) KR920009505B1 (enExample)
AT (1) ATE69241T1 (enExample)
CA (1) CA1339892C (enExample)
DE (2) DE3414831A1 (enExample)
DK (1) DK164940C (enExample)
ES (1) ES8603574A1 (enExample)
FI (1) FI90436C (enExample)
GR (1) GR850941B (enExample)
HU (1) HU210111B (enExample)
IE (1) IE59460B1 (enExample)
IL (1) IL74947A (enExample)
MA (1) MA20411A1 (enExample)
NO (1) NO171983C (enExample)
NZ (1) NZ211827A (enExample)
PH (1) PH25251A (enExample)
PT (1) PT80300B (enExample)
ZA (1) ZA852900B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
US5157004A (en) * 1986-12-27 1992-10-20 Takeda Chemical Industries, Ltd. Polypeptides and production thereof
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
JP2003513681A (ja) * 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
WO2004005341A2 (en) * 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
US20050003533A1 (en) * 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
US20060251619A1 (en) * 2005-05-04 2006-11-09 Gilles Borrelly Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
WO2008121461A2 (en) * 2007-02-26 2008-10-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Vaccine for activating helper function of cd8+ tcells
BG66517B1 (bg) * 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
JP4821891B2 (ja) * 2009-07-01 2011-11-24 トヨタ自動車株式会社 電池制御システム及び車両
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
CN113166261A (zh) 2018-10-11 2021-07-23 印希比股份有限公司 B7h3单域抗体及其治疗性组合物
AU2019356573B2 (en) 2018-10-11 2025-12-18 Inhibrx Biosciences, Inc. PD-1 single domain antibodies and therapeutic compositions thereof
JP7611820B2 (ja) 2018-10-11 2025-01-10 インヒブルクス バイオサイエンシズ インコーポレイテッド Ｄｌｌ３シングルドメイン抗体およびその治療用組成物
US12590169B2 (en) 2018-10-11 2026-03-31 Inhibrx Biosciences, Inc. 5T4 single domain antibodies and therapeutic compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
HU210111B (en) 1995-02-28
DK176285A (da) 1985-10-20
US4832959A (en) 1989-05-23
ZA852900B (en) 1985-11-27
JPH0745516B2 (ja) 1995-05-17
EP0161504A1 (de) 1985-11-21
CA1339892C (en) 1998-06-02
FI851529L (fi) 1985-10-20
FI851529A0 (fi) 1985-04-17
IE850995L (en) 1985-10-19
FI90436B (fi) 1993-10-29
DK164940C (da) 1993-02-01
IE59460B1 (en) 1994-02-23
KR850007274A (ko) 1985-12-02
DK176285D0 (da) 1985-04-18
IL74947A0 (en) 1985-08-30
DE3414831A1 (de) 1985-10-31
PT80300B (pt) 1987-09-30
MA20411A1 (fr) 1985-12-31
DK164940B (da) 1992-09-14
IL74947A (en) 2000-06-01
JPH07100037B2 (ja) 1995-11-01
PH25251A (en) 1991-03-27
NO171983C (no) 1993-05-26
JPH06153957A (ja) 1994-06-03
JPS60233100A (ja) 1985-11-19
PT80300A (de) 1985-05-01
NO851564L (no) 1985-10-21
ATE69241T1 (de) 1991-11-15
DE3584579D1 (de) 1991-12-12
ES542337A0 (es) 1985-12-16
GR850941B (enExample) 1985-11-25
NO171983B (no) 1993-02-15
KR920009505B1 (ko) 1992-10-17
EP0161504B1 (de) 1991-11-06
HUT37815A (en) 1986-02-28
ES8603574A1 (es) 1985-12-16
FI90436C (fi) 1994-02-10

Similar Documents

Publication Publication Date Title
GR850941B (enExample)
AU566348B2 (en) Yeast hybrid vectors and their use for the production of polypeptides
EP0174367A4 (en) HOSTS AND METHODS FOR PRODUCING RECOMBINANT PRODUCTS IN LARGE QUANTITIES.
FI853056A0 (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
FI103731B1 (fi) Uusia, tekijä VIII-aktiivisuutta omaavia proteiineja koodittava DNA-sekvenssi ja menetelmä näiden proteiinien valmistamiseksi
ATE54167T1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
IL75963A (en) Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them
AU589896B2 (en) A genetic engineering process for the preparation of human interleukin-2 and means for carrying out this process
DE69012377D1 (de) Polypeptid und dessen Herstellung.
DE68927009D1 (de) EXPRESSION UND PROZESSIERUNG VON ACETYLIERTEN FGFs IN HEFEN
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
IE872531L (en) Preparation of salmon calcitonin by genetic engineering, and¹means for carrying out this process